| Quantitative computed tomography is unreliable for measurement of bone mineral density in inadequately chelated adolescent patients with β-thalassemia major: A case-control study. | |
| | |
MedLine Citation:
|
PMID: 21225919 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
BACKGROUND: Utility of quantitative computed tomography (QCT) for assessment of bone mineral density (BMD) in patients with thalassemia is not fully established. Majority of patients with thalassemia in India receive suboptimal iron chelation. There is paucity of data on BMD in this population. Aim was to assess BMD by lumbar QCT in adolescent patients with transfusion dependent β-thalassemia major and compare with controls. PROCEDURE: Study was conducted prospectively, over 15 months. Single energy QCT was performed through first three lumbar vertebrae. RESULTS: Forty-five patients were enrolled (age: 10-19 years). Thirty-eight normal siblings of patients with thalassemia patients served as controls. Forty percent patients weighed <3rd percentile, 64% were stunted, and 40% had suboptimal sexual maturity scores. Eighteen (40%) patients were on iron chelation with deferiprone. Mean serum ferritin was 2,800 ± 1,473 ng/ml. Mean BMD (mg/cu mm) of cases and controls was 194.5 ± 27.1 and 170.4 ± 28.84, respectively (P = 0.0002). The mean BMD of patients with ferritin <2,000 ng/ml and those with a higher ferritin was 181.2 ± 14.9 and 196.7 ± 25, respectively (P = 0.07). The finding of increased BMD in patients with thalassemia is in stark contrast to published reports. Patients had several risk factors for low BMD, including growth retardation, delayed puberty, and iron overload. CONCLUSION: Single energy QCT of lumbar vertebrae is not reliable for measurement of BMD in inadequately chelated patients with β-thalassemia major. The deposition of iron in bone tissue may result in increased X-ray attenuation values of trabecular bone. Pediatr Blood Cancer 2011;56:409-412. © 2010 Wiley-Liss, Inc. |
| | |
Authors:
|
Deepak Bansal; S Venkateshwaran; N Khandelwal; R K Marwaha |
Related Documents
:
|
7841709 - Gastro-oesophageal reflux and oesophageal dysfunction in children and adolescents with ... 17389779 - Proton pump inhibitor improves breath marker in moderate asthma with gastroesophageal r... 19260789 - Primary versus secondary esophageal motility disorders: diagnosis and implications for ... 18959649 - Myotomy for achalasia: to wrap or not to wrap? 1282549 - Neopylorus: a functional reflux-free gastroenteral anastomosis. 8368919 - Gastroesophageal reflux and laryngeal disease. 15379619 - Antiplatelet therapy in peripheral arterial disease. 18271679 - Chromogranin a, a member of neuroendocrine secretory proteins as a selective marker for... 10924299 - Cardiovascular risk and therapeutic benefit of coronary interventions for patients with... |
Publication Detail:
|
Type: Journal Article Date: 2010-11-28 |
Journal Detail:
|
Title: Pediatric blood & cancer Volume: 56 ISSN: 1545-5017 ISO Abbreviation: Pediatr Blood Cancer Publication Date: 2011 Mar |
Date Detail:
|
Created Date: 2011-01-12 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101186624 Medline TA: Pediatr Blood Cancer Country: United States |
Other Details:
|
Languages: eng Pagination: 409-12 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Wiley-Liss, Inc. |
Affiliation:
|
Hematology/Oncology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Postgraduate Institute of Medical Education and Research, Chandigarh, India. deepakritu@yahoo.com. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: High-dose carboplatin-irinotecan-temozolomide: Treatment option for neuroblastoma resistant to topot...
Next Document: Sickle-cell disease in California: a population-based description of emergency department utilizatio...